KLK7 and cancer: It’s possible that the anti-proliferation induced by silencing KLK7 acts through protease-activated receptors-dependent proliferative pathways [22, 23], or the regulation of androgen-mediated proliferation pathways [24] and growth factor-mediated pathways [9], since these proliferation pathways are involved in several cancers where KLKs are deregulated.